Core Framework & Diagram How Does the Complement System Attack Pathogens?
July 28, 20261 Min Read Why Does Immune Attack Sometimes Spiral Out of Control?
July 28, 2026The complement system is your oldest immune weapon — it doesn't wait, it attacks directly
—— Thirty-plus proteins in cascade reaction, punching lethal holes in bacterial surfaces within minutes.
I. An ancient weapon on standby in your blood
In the evolutionary history of vertebrates, the adaptive immune system (T cells, B cells, antibodies) is a relatively 'new' invention — appearing approximately five hundred million years ago. But before adaptive immunity emerged, animals had already evolved effective strategies against pathogens. One of these is the complement system.
The complement system is far more ancient than adaptive immunity — primitive complement-like systems already exist in invertebrates (sea urchins, amphioxus). It's a core component of innate immunity, consisting of over thirty proteins, most existing as inactive precursors in blood and tissue fluid at total concentrations of several milligrams per milliliter of plasma, continuously in a 'ready on standby' state.
The complement system's most fascinating property is its 'spontaneous activation' capacity: regardless of whether antibodies are present, regardless of whether immune cells have arrived, under certain conditions (particularly when specific chemical structures are present on pathogen surfaces), complement can automatically activate. No waiting for adaptive immunity to respond required.
This makes complement one of the fastest immune responses after infection: within the first few minutes of pathogen invasion, complement can begin depositing and marking on bacterial surfaces, and initiating killing programs — far faster than neutrophil arrival (30–60 minutes), and far faster than specific T cells and antibodies forming (7–14 days).
2. Three activation pathways: same destination, different triggers
Alternative pathway: the oldest, most spontaneous
Blood plasma's C3 protein spontaneously hydrolyzes at a low rate, producing small amounts of C3(H2O). This hydrolysis product combines with factor B to form a 'fluid-phase C3 convertase.' Near normal human cells, multiple regulatory proteins (factor H, CR1) rapidly degrade this convertase, preventing overactivation. But on bacterial surfaces, these regulatory proteins can't function effectively — C3b can stably deposit on bacterial surfaces, recruiting factors B and D to form a stable 'surface C3 convertase' (C3bBb). This convertase then cleaves more C3, forming a self-amplifying cycle. The alternative pathway's elegance: it doesn't need any 'recognition' signal to start — it relies on the difference between 'regulatory proteins present on human cells, not present on bacterial surfaces' to distinguish self from non-self.
Classical pathway: requires antibody participation
When IgM or IgG antibodies bind to antigens, the Fc end undergoes conformational changes and can bind plasma C1q protein. C1q binding activates C1r and C1s proteases linked to it, which then cleave C4 and C2, producing C4b2a — the C3 convertase. The classical pathway connects innate immunity (complement) with adaptive immunity (antibodies): 'when antibodies are present, use them to trigger stronger complement killing' — a collaborative mechanism.
Lectin pathway
Triggered by mannose-binding lectin (MBL) recognizing mannose on bacterial surfaces — doesn't require antibodies; after activation proceeds the same as the classical pathway. Three pathways, each with distinct roles, ensuring complement can be activated across different states — with antibodies, without antibodies, or when specific sugar chains are present on surfaces.
3. C3: the complement system's central hub
Among all complement proteins, C3 is the most critical — it's the common convergence point of all three activation pathways, and the common starting point for complement's three core functions (opsonization, inflammation, direct killing). C3 is cleaved by C3 convertases into two fragments: C3a and C3b. This single cleavage step simultaneously initiates three downstream functional pathways.
C3b: opsonization's key molecule
C3b's structure contains a highly reactive thioester bond that can rapidly form covalent bonds with nearby bacterial surfaces, 'welding' C3b to the bacterium. Large amounts of C3b depositing on bacterial surfaces form 'opsonin labels.' Macrophages and neutrophils carry complement receptors (CR1, recognizing C3b) that can bind these opsonized bacteria, dramatically improving phagocytic efficiency. This complements IgG opsonization: when antibodies haven't yet formed, complement C3b opsonization is an important auxiliary mechanism for phagocytes to recognize bacteria — connecting innate immunity (complement) to phagocytic efficiency (phagocytes).
C3a and C5a: inflammatory signals
C3a is a potent 'anaphylatoxin' that acts on C3aR receptors on mast cells and basophils, triggering release of histamine and other inflammatory mediators, increasing vascular permeability (allowing more immune cells into the infection site), and directly attracting neutrophils. C5a, produced from C5 cleavage, is a far more potent anaphylatoxin than C3a — its chemotactic and mast cell-activating effects are tens of times stronger. In sepsis, massive C5a is an important contributor to uncontrolled systemic inflammation.
4. The membrane attack complex (MAC): the ultimate pore-punching weapon
The complement cascade's ultimate product is the membrane attack complex (MAC) — one of the most sophisticated biochemical 'wall-breaching' machines discovered to date.
After C5 cleavage produces C5b, C5b binds C6 and C7 to form the C5b67 complex, whose hydrophobic end is exposed and inserts into bacterial lipid bilayers. Then C8 binds and begins punching a small pore in the membrane. Finally, several C9 protein molecules polymerize to form a transmembrane channel spanning the bacterial cell membrane, with a diameter of approximately ten nanometers.
This pore's damage mechanism is direct and lethal: bacteria maintain normal internal environments by relying on intact cell membranes to control osmotic pressure and ion concentration differences. After MAC pores open, water molecules and various ions flow uncontrolled — bacteria unable to maintain membrane integrity cannot sustain normal internal environments, ultimately dying from osmotic imbalance (swelling and rupture) or metabolic collapse from ion imbalance.
MAC is particularly effective against Gram-negative bacteria (which have an outer membrane — the outer membrane lipid bilayer is MAC's target). Against Gram-positive bacteria (which have a thick cell wall protecting the membrane from direct MAC penetration), effects are limited. This explains why people with congenital complement terminal component deficiencies (C5-C9) are particularly susceptible to Neisseria meningitidis infections — their MAC formation capacity is impaired, drastically reducing their ability to directly kill these bacteria. Meningococcus replicates extremely rapidly, often causing explosive septicemia within hours with very high mortality — directly proving MAC's indispensable role in fighting this infection.
5. Complement dysregulation and disease: when this weapon turns on the self
The complement system is a powerful weapon — but also a dangerous one requiring precise regulation. When regulatory control fails, complement activation can attack host cells, causing serious disease.
Paroxysmal nocturnal hemoglobinuria (PNH)
One of the most typical diseases of complement regulatory failure. Normal red blood cells carry complement regulatory proteins DAF (CD55) and CD59 on their surfaces, protecting themselves from MAC attack. PNH patients have some hematopoietic stem cells with PIGA gene mutations, causing differentiated red blood cells to lack these GPI-anchored protective proteins. Unprotected red blood cells are continuously attacked and destroyed by the complement system (particularly the alternative pathway), causing chronic hemolytic anemia. The anti-C5 monoclonal antibody eculizumab blocks C5 cleavage, preventing MAC formation and effectively protecting patients' red blood cells — a milestone in complement-targeted therapy.
SLE and complement consumption
In active SLE, serum complement (C3, C4) levels falling is an important laboratory indicator. Large amounts of immune complexes (autoantibody-autoantigen) continuously activate the classical pathway, consuming C3 and C4. Simultaneously, overactivated complement damages glomeruli — an important pathogenic mechanism for lupus nephritis.
Frequently Asked Questions